David Perlmutter

Professor of Pediatrics, Spencer T and Ann W Olin Distinguished Professor in the School of Medicine, George and Carol Bauer Dean of the School of Medicine

    Willing to Mentor

    Available to Mentor:

    PhD/MSTP Students

    • 20428
    1983 …2022

    Research activity per year

    Personal profile

    Research interests

    As a physician-scientist, Perlmutter is internationally recognized for his research on alpha-1 antitrypsin deficiency (ATD), a genetic disorder in which accumulations of a misfolded protein can cause severe liver damage. His work has led to advances in the understanding of how cells dispose of misfolded proteins that cause cellular dysfunction as well as the development of a pipeline of ATD drugs that could eliminate the need for liver transplantation in those with the disorder. Since drugs in this pipeline target and enhance autophagy, a cellular degradation pathway which is critical for the functioning of all cells and declines with age, they also represent exciting candidates for prevention of cognitive decline and other degenerative diseases of aging. Through his research, his team has recently discovered a lead candidate drug that targets a natural cellular pathway in a way that may slow, or even prevent, age-dependent degenerative diseases of the liver, heart, and nervous system.

    Available to Mentor:

    • PhD/MSTP Students


    Dive into the research topics where David Perlmutter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or